NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/24/2023
Back to search
Official data from USPTO
KAIZO CLINICAL RESEARCH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
KAIZO CLINICAL RESEARCH
ST13
US500000090030237Class
42
Filing
90030237
Registration
6959732
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
01/24/2023
Trademark type
Word
Nice classes
42
Filing date
07/01/2020
Registration date
01/24/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/24/2023
Last transaction
01/24/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
06/09/2019
First use in commerce
06/09/2019
Drawing code
4
Owner type
03
Owner location
Washington, DC, US
Examiner
HOWELL, MATTHEW P
Law office
N50
Current location
TMO LAW OFFICE 123
Holders and representatives
Holders
American Operations, Inc.
Representatives
Michael S. Gottlieb MOMENTUM LAW GROUP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Clinical research in the field of paintreatment and prevention of musculoskeletal disordersfitness and other health and wellness interventions; Medical and scientific researchconducting clinical trials for others
Publications
History of USPTO decisions and trademark events.
29 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/24/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/08/2022
PUBO
PUBLISHED FOR OPPOSITION
11/08/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/19/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/04/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/08/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/07/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/07/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
06/07/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/02/2022
GNRT
NON-FINAL ACTION E-MAILED
06/02/2022
CNRT
NON-FINAL ACTION WRITTEN
06/02/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
05/06/2022
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
09/13/2021
DOCK
ASSIGNED TO EXAMINER
04/21/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
02/10/2021
GNSL
LETTER OF SUSPENSION E-MAILED
02/10/2021
CNSL
SUSPENSION LETTER WRITTEN
02/10/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/19/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/19/2021
ALIE
ASSIGNED TO LIE
01/15/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/05/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/11/2020
GNRT
NON-FINAL ACTION E-MAILED
09/11/2020
CNRT
NON-FINAL ACTION WRITTEN
09/11/2020
DOCK
ASSIGNED TO EXAMINER
09/10/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/28/2020
NWAP
NEW APPLICATION ENTERED
07/04/2020
Continuous trademark protection
Get notified about every new filing that threatens KAIZO CLINICAL RESEARCH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.